Capula Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$207K Sell
700
-200
-22% -$59.4K ﹤0.01% 736
2025
Q4
$246K Buy
900
+300
+50% +$81.5K ﹤0.01% 536
2025
Q3
$162K Buy
600
+200
+50% +$54.4K ﹤0.01% 657
2025
Q2
$110K Buy
+400
New +$109K ﹤0.01% 491
2021
Q2
Sell
-8,300
Closed -$1.7M 780
2021
Q1
$1.7M Sell
8,300
-36,600
-82% -$7.21M 0.03% 308
2020
Q4
$8.18M Buy
+44,900
New +$7.64M 0.41% 67
2020
Q3
Sell
-20,900
Closed -$3.4M 167
2020
Q2
$3.4M Buy
+20,900
New +$3.75M 0.12% 167
2020
Q1
Sell
-1,000
Closed -$201K 376
2019
Q4
$201K Sell
1,000
-13,700
-93% -$2.81M ﹤0.01% 344
2019
Q3
$3.11M Buy
+14,700
New +$3.07M 0.07% 195

Other funds holding CME

Capula Management's CME Position: Q1 2026 in Review

Capula Management sold out of CME Group (CME) in Q1 2026, closing a stake of 35 shares — an estimated $10.4K sold.

Capula Management first reported a position in CME in Q2 2020 and held it in 7 quarters. The position peaked at $425K in Q3 2021. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Capula Management reported no remaining CME Group position as of Q1 2026 after selling out during the quarter.
  • Capula Management sold 35 CME Group shares in Q1 2026, an estimated $10.4K.
  • Capula Management first reported a position in CME Group in Q2 2020 and held it in 7 quarters.
  • Capula Management's CME Group position peaked at $425K in Q3 2021.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.